School Of Medicine

Consuelo Hopkins Wilkins, professor of medicine in the School of Medicine and vice president for health equity at Vanderbilt University Medical Center, has received one of the highest honors in health and medicine. Read More

A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women. Read More

A new study sheds light on how molecular subsets within the tumors of kidney cancer patients determine treatment outcomes and underscores the importance of personalized medicine in making therapy decisions. Read More

Findings from a national study published Nov. 9 in the Journal of the American Medical Association (JAMA) “do not support” the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19, the report concludes. Read More

Angelika Amon, PhD, a pioneering cell and molecular biologist and winner of the 2018 Vanderbilt Prize in Biomedical Science, died Oct. 29 from cancer. She was 53. Read More

Biologists reveal that tissue perturbations by chemotherapy agents promote stem cell expansion and that fibroblast cells exhibit unexpected, immune-like behavior. Read More

The VBI recently marked its 20th anniversary, a span that has seen the institute’s wide-ranging missions—including administering the university’s Neuroscience Graduate Program, as well as postdoctoral training and community outreach—steadily coalesce under a single umbrella. Read More

A new paper proposes an ethical way to test drug safety during pregnancy by using electronic health data to conduct "virtual" drug trials. Read More

Lung disease experts at Vanderbilt University Medical Center and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children. Read More

Nancy Carrasco has found that the environmental pollutant perchlorate, found in drinking water in 49 states, is more dangerous than we knew. Read More

From the front lines of patient care to collaborating with scientists across the globe searching for treatments and vaccines, Vanderbilt University Medical Center and Vanderbilt University researchers have been working for months to combat the COVID-19 pandemic. Read More

Researchers at Vanderbilt University Medical Center are leading a nationwide study to determine the rate of novel coronavirus infection in U.S. children and their families. Read More

Rates of neonatal abstinence syndrome have plateaued after 20 years of increasing frequency across the country, according to a new study published in Health Affairs. Read More

Vanderbilt University Medical Center is playing a key role in the HERO program, a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine will protect them, their patients and their families from COVID-19. Read More

Vanderbilt University Medical Center is leading a clinical trial to understand if a well-known drug used for malaria and rheumatologic conditions is safe and effective in treating hospitalized adults with COVID-19. Read More

In Southern states that expanded their Medicaid programs under the Affordable Care Act, adults experienced lower rates of decline in both physical and mental health, according to a new Vanderbilt analysis. Read More

The Vanderbilt Microbiome Initiative is receiving attention for its role as a standard bearer for other microbiome programs, thanks to a new article on the importance and emergence of microbiome centers – academic hubs of microbiome-related research. Read More

This fall Vanderbilt welcomed its newest faculty members to campus, and their impact is already being felt, both in the classroom and through their wide-ranging research. Read More

IT security measures implemented following data breaches at hospitals may delay care when time is of the essence, according to a new analysis. Read More

Vanderbilt University’s F. Peter (Fred) Guengerich, PhD, and Elaine Sanders-Bush, PhD, are among 22 prominent scientists named this week to the inaugural class of fellows of the American Society for Pharmacology and Experimental Therapeutics (ASPET). Read More